In a legal tussle that has garnered global attention, pharmaceutical giant AstraZeneca has made a startling admission regarding its Covid-19 vaccine, known under various brand names such as Covishield and Vaxzevria.
In a pivotal moment during court proceedings, AstraZeneca has conceded that its vaccine can, in very rare instances, lead to severe side effects, including a condition known as Thrombosis with Thrombocytopenia Syndrome (TTS), which is characterized by blood clots and low platelet counts.
This admission comes amidst a class-action lawsuit filed by several families alleging serious injuries and even deaths resulting from the vaccine.
The lawsuit, spearheaded by Jamie Scott, whose life took a tragic turn after receiving the AstraZeneca vaccine in April 2021, underscores the devastating impact of these rare side effects. Scott suffered a permanent brain injury, prompting legal action against the pharmaceutical behemoth.
AstraZeneca’s acknowledgment of the potential risks associated with its vaccine marks a significant turn in the ongoing legal battle, shedding light on the complexities and uncertainties surrounding vaccination efforts worldwide. However, the company remains steadfast in its defence against claims of widespread vaccine defects or overstated efficacy.
Despite its effectiveness in combating the Covid-19 pandemic, the AstraZeneca-Oxford vaccine has faced regulatory scrutiny and safety concerns. Notably, it is no longer administered in the UK due to these safety considerations.
As legal proceedings continue to unfold, affected individuals and their families are seeking fair compensation and recognition of vaccine-induced injuries. This admission by AstraZeneca could potentially lead to substantial payouts if the company acknowledges vaccine-induced illness or death in specific cases.
